下肢静脈瘤治療の世界市場：地域範囲別および予測

下肢静脈瘤治療の市場規模と予測

下肢静脈瘤治療の世界市場規模は、2024年に3億1,127万米ドルと評価され、2024年～2031年の間に6.76％のCAGRで成長する見込みで、2031年には5億2,530万米ドルに達すると予測されています。世界の静脈瘤治療は、しばしば脚に見られる腫れ、ねじれた静脈である静脈瘤の不快感や外観を緩和することを目的とした医療処置や治療を含みます。一般的な治療法には、硬化療法、レーザー治療、内生的切除術のような低侵襲手術が含まれます。これらの方法は、健康な静脈に血流を迂回させ、影響を受けた静脈を標的とし、閉じます。これらの治療法は、美容的な改善から、痛み、腫れ、循環器系の問題などのより深刻な症状への対処まで、幅広く応用されています。

世界の静脈瘤治療の将来の展望は有望であり、特に人口の高齢化と座りがちなライフスタイルがこの症状の有病率の上昇に寄与する中、低侵襲技術の進歩と認知度の向上が需要を牽引しています。

下肢静脈瘤治療の世界市場力学

主な市場促進要因：

下肢静脈瘤の有病率の増加：

下肢静脈瘤の有病率の増加：特に高齢化社会と座りがちなライフスタイルの人々の間で下肢静脈瘤の発生率が上昇していることが、世界の下肢静脈瘤治療市場の主な促進要因となっています。米国疾病予防管理センター（CDC）によると、米国では成人の約20％が静脈瘤を経験しており、その有病率は年齢とともに増加しています。このような患者数の増加が、非侵襲的な処置から高度な外科的介入に至るまで、効果的な治療オプションに対する需要を促進しています。

低侵襲治療オプションの進歩：

内因性レーザー治療（EVLT）やラジオ波焼灼療法（RFA）などの低侵襲処置の技術的進歩が、世界の下肢静脈瘤治療市場を前進させています。これらの処置は、従来の外科的方法と比較して、患者に回復時間の短縮、最小限の傷跡、高い成功率を提供します。このような侵襲性の低い選択肢への嗜好の高まりは、多くのヘルスケア環境において世界の下肢静脈瘤治療の標準治療となりつつあることから、市場の成長に反映されています。

意識の高まりと早期診断：

静脈瘤に対する認識の高まりと早期診断の重要性が市場の成長を促進しています。ヘルスケアプロバイダーや政府機関による公衆衛生キャンペーンや教育プログラムは、慢性静脈不全や下腿潰瘍など、未治療の静脈瘤に関連するリスクについて個人に知らせるのに役立っています。このような認識により、早期に治療を求める人が増え、市場の拡大に寄与しています。米国国立衛生研究所（NIH）が血管の健康に焦点を当てているようなイニシアチブは、早期介入を強調し、合併症が生じる前に治療を受けるよう患者を奨励しています。

支持的な政府政策とヘルスケア償還：

政府の政策とヘルスケア償還制度は、特に先進地域では下肢静脈瘤治療をますます支持しています。米国では、メディケアやその他の保険会社が、特に医学的に必要と判断された下肢静脈瘤治療に対して保険適用を行っています。この保険適用により、患者の自己負担額が減り、治療を受けやすくなるため、市場がさらに活性化します。政府のデータによると、下肢静脈瘤治療に対するメディケアの支出は着実に増加しており、これはこれらの治療の需要の高まりと利用しやすさを反映しています。

主な課題

高度治療へのアクセス制限：

内因性レーザー治療やラジオ波焼灼療法などの高度な下肢静脈瘤治療は、特に農村部や医療サービスが行き届いていない地域では、高額で広く利用できないことが多いです。多くの患者は、より侵襲的で回復に長い時間を要する従来の外科的選択肢しか利用できない場合があります。高額な費用と専門クリニックの不足により、多くの患者が最も効果的で侵襲の少ない治療法を利用することは困難です。

治療結果のばらつき：

最新の治療法は一般的に有効であるが、患者の状態、治療法の種類、ヘルスケア提供者の技量によって治療結果にばらつきが生じることがあります。治療後に静脈瘤が再発したり、症状が不完全に消失したりする患者さんもいます。さらに、特に複雑な症例や経験の浅い医療従事者が治療を行う場合、神経損傷や皮膚熱傷などの合併症のリスクを伴うことがあります。

患者のコンプライアンスと治療後のケア：

世界規模の下肢静脈瘤治療を効果的に行うには、多くの場合、治療そのものだけでなく、圧迫ストッキングの着用や生活習慣の改善など、治療後のケアも遵守する必要があります。しかし、推奨されるアフターケアを怠ったり、日常生活に必要な調整を怠ったりする患者もいるため、患者のコンプライアンスは課題となり得ます。

保険適用と償還の問題：

下肢静脈瘤の治療に対する保険適用範囲はさまざまで、医療上の必要性よりも美容上の処置とみなす保険会社もあります。そのため、自己負担額を支払えない人の治療へのアクセスが制限されることがあります。保険が適用される場合でも、払い戻し手続きは複雑で時間がかかるため、患者と医療提供者の両方が特定の治療法を選択することを躊躇する場合があります。

主な動向：

低侵襲治療の台頭：

静脈内レーザー治療（EVLT）やラジオ波焼灼療法（RFA）などの低侵襲治療は、ますます人気が高まっています。これらの治療法は、従来の外科的方法と比較して、回復時間の短縮、痛みの軽減、傷跡の最小化が可能です。

超音波ガイド下治療の増加：

下肢静脈瘤治療における超音波技術の統合により、治療の精度と有効性が向上しています。超音波ガイド下発泡硬化療法や静脈内治療では、問題のある静脈を正確に狙い撃ちすることができるため、治療成績が向上します。この動向は、特に従来の方法ではアクセスが困難な深部静脈に対して、より正確で安全かつ迅速な処置が望まれていることに起因しています。

美容治療に対する需要の高まり：

下肢静脈瘤が美容に与える影響に対する認識が高まるにつれ、医学的な理由だけでなく、美容的な改善を目的として治療を希望する患者が増加しています。この動向に拍車をかけているのが、ダウンタイムを最小限に抑えながら効果的な美容効果をもたらす非侵襲的・低侵襲的治療法の進歩です。

技術の進歩と革新：

治療機器や技術における絶え間ない革新が、静脈瘤管理の将来を形成しています。新しいレーザー技術、改良されたカテーテル設計、および発泡硬化療法製剤の進歩により、治療効果と患者の快適性が向上しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 下肢静脈瘤治療市場：治療タイプ別

• 静脈内焼灼術
• 外科的静脈剥離術
• 外来静脈瘤切除術
• 圧迫療法

第5章 下肢静脈瘤治療市場：エンドユーザー別

• 病院および診療所
• 外来手術センター（ASCs）
• 専門静脈クリニック
• 在宅医療

第6章 下肢静脈瘤治療市場：静脈タイプ別

• 大伏在静脈
• 小伏在静脈
• 穿通静脈
• その他の表在静脈および深部静脈

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Medtronic plc
• AngioDynamics, Inc.
• Lumenis Ltd.（XIO Group）
• biolitec AG
• BTG plc（acquired by Boston Scientific Corporation）
• Syneron Medical Ltd.（Candela Corporation）
• Alma Lasers Ltd.（Sisram Medical Ltd.）
• AngioTech Inc.（Argon Medical Devices）
• Vascular Solutions Inc.（Teleflex Incorporated）
• Quanta System S.p.A.

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Varicose Vein Treatment Market Size and Forecast

Global Varicose Vein Treatment Market size was valued at USD 311.27 Million in 2024 and is projected to reach USD 525.3 Million by 2031 , growing at a CAGR of 6.76% from 2024 to 2031. Global varicose vein treatment involves medical procedures and therapies aimed at alleviating the discomfort and appearance of varicose veins, which are swollen, twisted veins often found in the legs. Common treatments include Sclerotherapy, laser therapy, and minimally invasive surgeries like endogenous ablation. These methods target and close off the affected veins, rerouting blood flow to healthier veins. The application of these treatments spans from cosmetic improvements to addressing more severe symptoms like pain, swelling, and circulatory issues.

The future scope of global varicose vein treatment is promising, with advancements in minimally invasive techniques and increased awareness driving demand, particularly as aging populations and sedentary lifestyles contribute to a higher prevalence of the condition.

Global Varicose Vein Treatment Market Dynamics

The key market dynamics that are shaping the global varicose vein treatment market include:

Key Market Drivers:

Increasing Prevalence of Varicose Veins:

The rising incidence of varicose veins, particularly among aging populations and individuals with sedentary lifestyles, is a major driver of the global varicose vein treatment market. According to Centers for Disease Control and Prevention (CDC), approximately 20% of adults in the United States experience varicose veins, with prevalence increasing with age. This growing patient population is driving demand for effective treatment options, ranging from non-invasive procedures to advanced surgical interventions.

Advancements in Minimally Invasive Treatment Options:

Technological advancements in minimally invasive procedures, such as endogenous laser therapy (EVLT) and radiofrequency ablation (RFA), are propelling the global varicose vein treatment market forward. These procedures offer patients reduced recovery times, minimal scarring, and higher success rates compared to traditional surgical methods. The increasing preference for these less invasive options is reflected in the market's growth, as they are becoming the standard of care for global varicose vein treatment in many healthcare settings.

Rising Awareness and Early Diagnosis:

Increasing awareness of varicose veins and the importance of early diagnosis is driving market growth. Public health campaigns and educational programs by healthcare providers and government agencies are helping to inform individuals about the risks associated with untreated varicose veins, such as chronic venous insufficiency and leg ulcers. This awareness is leading to more people seeking treatment earlier, contributing to the market's expansion. Initiatives like the National Institutes of Health's (NIH) focus on vascular health emphasize early intervention, encouraging patients to seek treatment before complications arise.

Supportive Government Policies and Healthcare Reimbursement:

Government policies and healthcare reimbursement systems are increasingly supportive of varicose vein treatments, particularly in developed regions. In the United States, Medicare and other insurance providers cover a range of varicose vein treatments, especially when deemed medically necessary. This coverage reduces out-of-pocket costs for patients and encourages them to seek treatment, further driving the market. According government data, Medicare expenditures on varicose vein treatments have seen a steady increase, reflecting the growing demand and accessibility of these procedures.

Key Challenges:

Limited Accessibility to Advanced Treatments:

Advanced varicose vein treatments, such as endogenous laser therapy and radiofrequency ablation, are often expensive and not widely available, particularly in rural or underserved areas. Many patients may only have access to traditional surgical options, which can be more invasive and require longer recovery times. The high cost and lack of specialized clinics make it difficult for many individuals to access the most effective and minimally invasive treatment options.

Variability in Treatment Outcomes:

While modern treatments are generally effective, there can be variability in outcomes depending on the patient's condition, the type of treatment, and the skill of the healthcare provider. Some patients may experience recurrence of varicose veins or incomplete resolution of symptoms after treatment. Additionally, certain procedures may carry risks of complications, such as nerve damage or skin burns, particularly in complex cases or when performed by less experienced practitioners.

Patient Compliance and Post-Treatment Care:

Effective global varicose vein treatment often requires not just the procedure itself but also adherence to post-treatment care, such as wearing compression stockings and following lifestyle changes. However, patient compliance can be a challenge, as some individuals may neglect recommended aftercare or fail to make necessary adjustments in their daily routines.

Insurance Coverage and Reimbursement Issues:

Insurance coverage for varicose vein treatments varies widely, with some insurers considering it a cosmetic procedure rather than a medical necessity. This can limit access to treatment for those who cannot afford out-of-pocket expenses. Even when coverage is available, reimbursement processes can be complex and time-consuming, deterring both patients and healthcare providers from pursuing certain treatment options.

Key Trends:

Rise of Minimally Invasive Procedures:

Minimally invasive treatments, such as endovenous laser therapy (EVLT) and radiofrequency ablation (RFA), are becoming increasingly popular. These procedures offer reduced recovery times, less pain, and minimal scarring compared to traditional surgical methods.

Increasing Use of Ultrasound-Guided Therapies:

The integration of ultrasound technology in varicose vein treatments has improved the accuracy and effectiveness of procedures. Ultrasound-guided foam Sclerotherapy and endovenous treatments allow for precise targeting of problematic veins, enhancing treatment outcomes. This trend is driven by the desire for more precise, safer, and quicker procedures, particularly for deeper veins that are difficult to access through traditional methods.

Growing Demand for Aesthetic Treatments:

As awareness of varicose veins' cosmetic impact increases, more patients are seeking treatment not only for medical reasons but also for aesthetic improvements. This trend is fueled by advancements in non-invasive and minimally invasive treatments that provide effective cosmetic results with minimal downtime.

Technological Advancements and Innovation:

Continuous innovations in treatment devices and techniques are shaping the future of varicose vein management. New laser technologies, improved catheter designs, and advancements in foam Sclerotherapy formulations are enhancing treatment efficacy and patient comfort.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Varicose Vein Treatment Market Regional Analysis

Here is a more detailed regional analysis of the global varicose vein treatment market:

North America:

North America stands as the dominant region in the global varicose vein treatment market, primarily due to its advanced healthcare infrastructure, high patient awareness, and substantial investments in medical technology. The United States, in particular, is a key player, with a robust healthcare system and a high prevalence of varicose veins among its aging population. According the U.S. Centers for Disease Control and Prevention (CDC), approximately 20-25% of adults in the U.S. are affected by varicose veins, driving substantial demand for effective treatments. The presence of major medical device manufacturers and leading research institutions further contributes to North America's market leadership.

The market is also bolstered by significant government support and healthcare policies aimed at improving patient access to varicose vein treatments. The U.S. Department of Health and Human Services (HHS) has been actively promoting innovations in minimally invasive procedures through various grants and funding opportunities. This growth is driven by advancements in treatment technologies and an increasing focus on reducing healthcare costs through efficient, minimally invasive procedures. The strong healthcare framework and ongoing investment in medical advancements ensure North America's continued dominance in the global varicose vein treatment market.

Asia Pacific:

Asia Pacific is the fastest-growing region in the global varicose vein treatment market, driven by several key factors including rising healthcare access, increasing patient awareness, and a growing elderly population. The region's expanding healthcare infrastructure, coupled with rising disposable incomes and a surge in aesthetic procedures, contributes to the rapid growth. According to data from the World Health Organization (WHO), the Asia Pacific region is expected to see a compound annual growth rate (CAGR) of approximately 7.5% in the Global Varicose Vein Treatment market through 2026. This growth is particularly evident in countries like China and India, where improvements in medical facilities and a rising focus on non-invasive treatments are significantly influencing market dynamics.

Governments in the region are also supporting the growth of the healthcare sector through various initiatives. For instance, the Indian government's National Health Mission includes provisions for enhancing healthcare services and increasing the availability of advanced medical treatments. Additionally, China's Healthy China 2030 initiative emphasizes improving healthcare access and quality, which includes expanding the availability of specialized treatments such as varicose vein interventions.

Global Varicose Vein Treatment Market: Segmentation Analysis

The Global Varicose Vein Treatment Market is segmented on the basis of By Treatment Type, By Product, By End User and By Geography.

Global Varicose Vein Treatment Market, By Treatment Type

• Endovenous Ablation
• Injection Sclerotherapy
• Surgical Ligation & Stripping
• Laser Ablations

Based on Type Treatment Mode, the Global Varicose Vein Treatment Market is segmented into Endovenous Ablation, Injection Sclerotherapy, Surgical Ligation & Stripping, Laser Ablations. Endovenous Ablation is the dominant segment due to its widespread use and effectiveness in treating varicose veins with minimal invasiveness. This procedure, which includes both laser and radiofrequency ablation, is favored for its high success rate, shorter recovery time, and reduced risk of complications compared to traditional surgical methods. However, Injection Sclerotherapy is the fastest-growing segment, driven by its cost-effectiveness, simplicity, and increasing preference among patients for non-surgical options. The growing demand for aesthetic improvements and the rising awareness of this minimally invasive procedure are further fueling its rapid expansion in the market.

Global Varicose Vein Treatment Market, By Product

• Ablation Devices
• Venous Closure Products
• Surgical Products

Based on Product, the Global Varicose Vein Treatment Market is segmented into Ablation Devices, Venous Closure Products, Surgical Products. Ablation Devices are the dominant segment due to their established effectiveness in treating varicose veins through minimally invasive techniques such as laser and radiofrequency ablation. These devices are widely used because they offer high precision, reduced recovery times, and lower risk of complications compared to traditional surgical methods. Conversely, Venous Closure Products are the fastest-growing segment. This growth is driven by innovations in closure techniques, such as newer, more effective vein sealing technologies and advancements in catheter designs, which are increasingly favored for their minimal invasiveness and improved patient outcomes.

Global Varicose Vein Treatment Market, By End User

• Hospitals
• Specialized Clinics
• Ambulatory Surgical Centers

Based on End User, the Global Varicose Vein Treatment Market is segmented into Hospitals, Specialized Clinics, Ambulatory Surgical Centers. Hospitals are the dominant segment due to their comprehensive medical facilities, which include advanced diagnostic tools and treatment options for varicose veins. Hospitals are equipped to handle a wide range of procedures, from minimally invasive to complex surgical interventions, making them the preferred choice for patients seeking thorough care. However, Specialized Clinics are the fastest-growing segment. This growth is driven by the increasing preference for targeted, specialized care and the rise of facilities dedicated solely to vein treatments, which offer focused expertise, personalized care, and advanced technologies.

Global Varicose Vein Treatment Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Varicose Vein Treatment Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region due to its advanced healthcare infrastructure, high patient awareness, and widespread adoption of innovative treatment technologies. The presence of well-established medical centers and significant investments in healthcare contribute to its leadership in the market. Conversely, Asia Pacific is the fastest-growing region, driven by increasing healthcare access, rising awareness of varicose vein treatments, and a growing elderly population.

Key Players

• The "Global Varicose Vein Treatment Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
• AngioDynamics, Inc., Medtronic, Syneron Medical Ltd., Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, WON TECH Co. Ltd., Intros Medical Laser GmbH, Energist Ltd., Dornier Medtech GmbH, Theraclion, I-VASC.
• Our
• market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
• Global Varicose Vein Treatment Market: Recent Developments
• In August 2024 Medtronic announced the launch of its next-generation radiofrequency ablation system, designed to improve precision and patient comfort. The new system incorporates advanced technology for real-time monitoring, which enhances the effectiveness of varicose vein treatments and reduces procedural complications.
• In July 2024 Boston Scientific unveiled its latest laser ablation device, which features enhanced energy delivery capabilities and improved catheter design. This innovation aims to provide more efficient and effective treatment for varicose veins, catering to the growing demand for minimally invasive procedures.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Varicose Vein Treatment Market, By Treatment Type

• Endovenous Ablation
• Surgical Vein Stripping
• Ambulatory Phlebectomy
• Compression Therapy

5. Varicose Vein Treatment Market, By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty vein clinics
• Homecare Settings

6. Varicose Vein Treatment Market, By Vein Type

• Great Saphenous Vein
• Small Saphenous Vein
• Perforator Veins
• Other Superficial and Deep Veins

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc
• AngioDynamics, Inc.
• Lumenis Ltd. (XIO Group)
• biolitec AG
• BTG plc (acquired by Boston Scientific Corporation)
• Syneron Medical Ltd. (Candela Corporation)
• Alma Lasers Ltd. (Sisram Medical Ltd.)
• AngioTech Inc. (Argon Medical Devices)
• Vascular Solutions Inc. (Teleflex Incorporated)
• Quanta System S.p.A.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References